These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 12967424

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Raynaud's phenomenon (primary).
    Pope J.
    Clin Evid; 2004 Dec; (12):1725-34. PubMed ID: 15865744
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Raynaud's phenomenon of the nipple: a preventable cause of breastfeeding failure?
    Lawlor-Smith LS, Lawlor-Smith CL.
    Med J Aust; 1997 Apr 21; 166(8):448. PubMed ID: 9140358
    [No Abstract] [Full Text] [Related]

  • 8. Nifedipine treatment of Raynaud's phenomenon in a paediatric age.
    Matucci Cerinic M, Falcini F, Bartolozzi G, Volpi M.
    Int J Clin Pharmacol Res; 1985 Apr 21; 5(1):67-9. PubMed ID: 3997315
    [Abstract] [Full Text] [Related]

  • 9. Raynaud's phenomenon and nifedipine.
    Kraus A.
    J Rheumatol; 1989 Jul 21; 16(7):1013. PubMed ID: 2597264
    [No Abstract] [Full Text] [Related]

  • 10. Nicardipine in the treatment of Raynaud's phenomenon: a randomized double-blind trial.
    Kahan A, Amor B, Menkès CJ, Weber S, Guérin F, Degeorges M.
    Angiology; 1987 Apr 21; 38(4):333-7. PubMed ID: 3555175
    [Abstract] [Full Text] [Related]

  • 11. Sildenafil for the treatment of Raynaud's phenomenon.
    Heymann WR.
    J Am Acad Dermatol; 2006 Sep 21; 55(3):501-2. PubMed ID: 16908357
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nisoldipine in primary Raynaud's phenomenon.
    Challenor VF, Waller DG, Francis DA, Francis JL, Mani R, Roath S.
    Eur J Clin Pharmacol; 1987 Sep 21; 33(1):27-30. PubMed ID: 3691593
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Recount of prostaglandin E1 therapy in a patient with Raynaud's phenomenon.
    DiGiovanni RL, Littlefield JM, Good RG.
    J Am Osteopath Assoc; 1995 Oct 21; 95(10):572. PubMed ID: 8557544
    [No Abstract] [Full Text] [Related]

  • 19. Clinical inquiries. What is the evaluation and treatment strategy for Raynaud's phenomenon?
    Tagliarino H, Purdon M, Jamieson B, Hoekzema G.
    J Fam Pract; 2005 Jun 21; 54(6):553-5. PubMed ID: 15939010
    [No Abstract] [Full Text] [Related]

  • 20. Nifedipine in pulmonary arterial hypertension. Importance of Raynaud's phenomenon.
    Fisher J, Mack RJ, Likier HM, Schiff AN, Borer JS.
    Chest; 1987 Sep 21; 92(3):400-5. PubMed ID: 3622018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.